HM31 Breast cancer in young women – age a risk factor only in those not given chemotherapy
Hanna Fredholm(Karolinska University Hospital), Irma Fredriksson(Karolinska University Hospital), Linda S. Lindström(Uppsala University), Fredrik Pontén(Uppsala University), Sonja Eaker(Uppsala University Hospital), Jan Frisell(Karolinska University Hospital), Hans Garmo(Uppsala University), Henrik Lindman(Uppsala University), Lars Holmberg(Uppsala University), Jonas Bergh(Karolinska Institutet), K. Magnusson
Cited by 1
Related Papers
Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
|The Lancet|2014|4.7k
Pembrolizumab for Early Triple-Negative Breast Cancer
|New England Journal of Medicine|2020|3.1k
3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)
|Annals of Oncology|2016|2.1k